Department of Intensive Care Medicine, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
Emerg Med Australas. 2023 Dec;35(6):953-959. doi: 10.1111/1742-6723.14283. Epub 2023 Jul 17.
Optimal resuscitation of sepsis-induced hypotension is uncertain, particularly the role of restrictive fluid strategies, leading to variability in usual practice. The objective of this study is to understand resuscitation practices in patients presenting to ED with early sepsis.
Design, participants and setting: Prospective, observational, multicentre, single-day, point-prevalence study enrolling adult patients present in 51 Australian and New Zealand ICUs at 10.00 hours, 8 June 2021.
Site-level data on sepsis policies and patient-level demographic data, presence of sepsis and fluid and vasopressor administration in the first 24 h post-ED presentation.
A total of 722 patients were enrolled. ED was the ICU admission source for 222 of 722 patients (31.2%) and 78 of 222 patients (35%) met the criteria for sepsis within 24 h of ED presentation. Median age of the sepsis cohort was 61 (48-72) years, 58% were male and respiratory infection was the commonest cause (53.8%). The sepsis cohort had a higher severity of illness than the non-sepsis cohort (144/222 patients) and chronic immunocompromise was more common. Of 78 sepsis patients, 55 (71%) received ≥1 fluid boluses with 500 and 1000 mL boluses equally common (both 49%). In the first 24 h, 2335 (1409-3125) mL (25.3 [13.2-42.9] mL/kg) was administered. Vasopressors were administered in 53 of 78 patients (68%) and for 25 patients (47%) administration was peripheral.
ICU patients presenting to the ED with sepsis receive less fluids than current international recommendations and peripheral vasopressor administration is common. This finding supports the conduct of clinical trials evaluating optimal fluid dose and vasopressor timing for early sepsis-induced hypotension.
脓毒症性低血压的最佳复苏方法仍不确定,尤其是限制液体策略的作用,导致临床实践存在差异。本研究旨在了解急诊科就诊的早期脓毒症患者的复苏情况。
设计、参与者和设置:这是一项前瞻性、观察性、多中心、单日、时点患病率研究,纳入 2021 年 6 月 8 日 10 点在澳大利亚和新西兰 51 家 ICU 中出现的成年患者。主要观察指标:脓毒症相关政策的站点水平数据以及患者人口统计学数据、入院时存在脓毒症和 24 小时内液体和血管加压素的使用情况。
共纳入 722 例患者。722 例患者中,222 例(31.2%)来源于 ICU 病房,222 例患者中有 78 例(35%)在急诊科就诊后 24 小时内符合脓毒症标准。脓毒症组患者的中位年龄为 61(48-72)岁,58%为男性,最常见的感染源为呼吸道感染(53.8%)。脓毒症组比非脓毒症组患者的病情更严重(144/222 例),且慢性免疫功能不全更常见。在 78 例脓毒症患者中,55 例(71%)接受了≥1 次液体冲击,500 和 1000ml 冲击量同样常见(均为 49%)。在最初 24 小时内,给予了 2335(1409-3125)ml(25.3[13.2-42.9]ml/kg)液体。在 78 例患者中,53 例(68%)给予了血管加压素,其中 25 例(47%)给予了外周血管加压素。
在急诊科就诊的 ICU 患者接受的液体量少于目前的国际推荐量,外周血管加压素的应用较为常见。这一发现支持开展临床试验,评估早期脓毒症性低血压的最佳液体剂量和血管加压素时机。